Profluent applies Large Language Models (LLMs) to the language of proteins, moving biology from discovery to design. Their platform, which created the open-source OpenCRISPR-1, 'authors' functional proteins and gene editors that do not exist in nature. Profluent is positioned to revolutionize therapeutics and biomanufacturing by generating custom biological tools with precision and speed. The approach compresses traditional R&D timelines, offering systemic cost reductions in therapeutic development and biological engineering.